Vi bistår våre kunder med markedsstrategier både digitalt og analogt. Zebra Media er et nytenkende og kreativt mediebyrå som har spesialisert seg på strategier, kreativt design og innovativ markedsteknologi. Zebra Media er et medie- og reklamebyrå med fokus på å hjelpe bedrifter å finne de rette løsningene innen digital markedsføring og grafisk design.

Bile duct cancer is an aggressive form of cancer with an extremely poor overall five-year survival rate of just 2-5 %. Classified as an orphan disease, annual incidence in Europe and the United States of 15-22,000 patients, and a significantly higher incidence in Asia, makes it a major player and the deadliest of the gastrointestinal cancers. Only a small number of patients are eligible for a complete surgical resection by local resection or liver transplantation, and more than 50% of these relapse. The vast majority are treated by gemcitabine-based palliative chemotherapy with a life expectancy of 11 months, and five-year survival rate of zero %. Thus, there is an urgent and unmet medical need to develop new and better treatment strategies for these patients. The innovations developed by Seald are a result of adopting a multidisciplinary approach to the diagnosis and treatment of bile duct cancer, based on extensive drug sensitivity assays on living cancer cells, molecular biomarkers, DNA sequencing, extensive bioinformatics analyses and zebrafish models. Sealds’s holistic approach is unique with possible modes of action that can be used on other solid cancers. Our technology includes drug repurposing and innovation on new medical substances, diagnostics and methodology. The stipulated pharma market globally is USD 2.1-4.2 billion, in addition to the markets for diagnostics and platform technology

An intracellular approach to diagnostics – changing the way diagnostics approach blood tests. Pre Diagnostics is the first diagnostics company to focus on intracellular measurements of disease-specific biomarkers inside the blood cells. We extract disease-relevant information from biomarkers located inside specific blood cells called monocytes to provide actionable results for patients and practitioners.

"Lifeboats have killed more people than they have saved!" The statement is as far as I know unsupported, but widely known within the market of lifesaving equipment. Regulatory development, or rather a lack of such, has created a worldwide situation where lifesaving equipment on ships, ferries, cruise liners, you name it, have been torn between manufacturers, owners, service providers, and class and flag authorities, where all parties are biased by their commercial interest and their hopefully unconscious gamble that such equipment never has to be used. Not on their vessel. Not on my watch. The gamble is made with human lives at stake, and unfortunately, the odds are already written in blood. My system is based on my almost 20 years in this busyness. I have been a sailor who has trusted my own life on such equipment. I have been fortunate enough to use such equipment to save others. I have been responsible for the maintenance of such, I have worked with the leading manufacturers of such equipment as well as with companies providing service and inspections. I have also been part of the international organization responsible for the development of the rules for lifesaving equipment, and I have monitored this work closely for the last 10 years. I have seen all sides of the above-mentioned struggle. I know at the end of the day safety is at stake. I also have the solution. My system will benefit all parties and make equipment integrity and safety profitable for all. I am looking for a co-founder, CTO, and system developer to make my dream come true. I need someone with a passion to make a difference. Someone who values the thought of doing something nobody has done before, and who is willing to be in it for the long haul. I am sincerely looking forward to meeting you!

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

ZHOOTS AS er et selskap som driver med foto, video og inspeksjonsoppdrag med drone. ZHOOTS AS er sertifisert av luftfartstilsynet. Oppdragene er i hovedsak rettet mot eiendom og eiendomsutvikling. Dette innebærer blant annet foto til 3D modellering, tomteutvikling og eiendomsalg. ZHOOTS AS har tilholdsted på Sørlandet, men vi utfører gjerne oppdrag andre plasser i landet også. Ta kontakt for nærmere info: post@zhoots.com

Hei, mitt navn er Erik Johannesen og er gründer i det norske selskapet ID TAG TECHNOLOGY GROUP AS. Selskapet ID TAG TECHNOLOGY har en idé og teknologi som vi anser som støttende til innsamling av BIG DATA, og et utall andre muligheter innenfor dette konseptet. Vår ambisjon er at ID TAG TECHNOLOGY skal kan skape et nytt verdensomspennende markedsføringskonsept. ID TAG TECHNOLOGY sin patenterte teknologi/konsept har til hensikt å være en «plattform» for mange industrielle behov. Vi anser at vi kan lisensiere ut vår teknologi til logistikk, broadcast, marine, olje og gass mm. Utallige muligheter. Tenk deg at du tar et bilde med mobilkamera og kan se hvem som er på bildet med informasjon om vedkommende, samt at du kan se hvilken merkevare-/produsent som har produktene på bildet, i sanntid. Deretter trykker du på produktet på bildet som inneholder en url, og du blir sendt videre til produktets nettsted. Dette er ikke gjenkjennelses teknologi eller maskin learning, men rett informasjon som er skapt av de som ønsker å informere kundene i den store verden. ID TAG TECHNOLOGY ble etablert 2011, har en positiv PCT-rapport, og innleverte patentsøknader februar 2015 på en teknologi/konsept for å plassere/identifisere elektroniske tags/sensorer innenfor en billedramme i sanntid, både stillbilder og video/film i en rekke land. Både ideen og teknologien har oppfinnerhøyde. Teknologien som er beskrevet i patentsøknadene er utviklet/forsket på i samarbeid med SINTEF, og har pågått siden begynnelsen av 2011. Vi har nå utviklet en lab modell for å bevise at dette lar seg gjennomføre – dette kan du få se. ID TAG TECHNOLOGY GROUP har blitt innvilget patent i Norge, USA og Kina (2017). Det er for øvrig søkt patent i EPO, Russland, Hong Kong, Japan og Sør Korea. Søknadsprosessen går over all forventning. Teknologien kan benyttes både i profesjonelt utstyr og i personlige enheter som smarttelefoner og nettbrett/PC og egenutviklede hardwareprodukter for industrielle behov. Bruksområdene er mange, og vi har spesielt sett på kringkasting/film (produktplassering), markedsføring/varehandel, transport/distribusjon og sosiale medier. Vi ser store muligheter innenfor markedsføring og salg hvor interessenten har mer kontroll enn det som dagens trender tilsier.   Se gjerne våre illustrerende konsept filmer på vår hjemmeside: http://www.idtagtech.com  Med vennlig hilsen  Erik Johannesen Mob: +47 918 71 610 E-mail: erik.johannesen@bbnett.no Hjemmeside: http://www.idtagtech.com

Fjerner problemer med utmatting av sveis under subsea brønnhoder. Integreres i standard brønnhoder. Reduserer kostnad med mer enn 1 MNOK pr installert brønnhode sammenlignet med dagens teknologi Dokumentert funksjon gjennom produkt kvalifisering hos DnV og global riser analyser hos TechnipFMC. System testes hos TechnipFMC i en Innovasjon Norge innovasjonskontrakt med Vasshella Flexibles. Klar for pilot installasjon i 2018

Building on an extensive background in aviation and oil & gas, Astralution strives to offer long-term value to our clients by providing tailored UAV solutions for a range of industries. The combination of disruptive technologies with innovative software yields new systems that allow better decision-making, improved safety and efficiency whilst reducing operational downtime. We are currently working on the first in the world EX Zone 1 certified system with max support from Innovation Norway. We have signed with Rogaland Brann og Redning (County Fire Department) as our pilot client and are about to start an R&D project to test and modify our solutions for the fire department. We are looking for competent capital to strengthen our team and accelerate technology development. Astralution aims to provide streamlined visual communications solutions with purpose-built systems that improve efficiency at every stage, from the accuracy of the acquired data to the selective delivery of mission-critical information to the relevant decision-makers. Our unique partnerships with leading technology providers give us unparalleled access to satellite communications, asset management solutions, GIS applications and class-leading payloads and sensor technologies. Today, drone technology allows unique opportunities for data gathering, by bringing state-of-the-art equipment, such as FLIR or HD cameras, to previously inaccessible areas. By streamlining the process from collection to delivery, we aim to offer fast, effective and actionable data to our clients in various industries without compromising accuracy or reliability.

Fra Bioretur får du idag tilgang til den beste teknologien for slambehandling for oppdrettsnæringen, samtidig som du får en partner som tar hånd om slammet fra problem til bærekraftig utnyttelse. Ved å tegne en Bioreturavtale tar du lavere risiko, sikrer økonomisk forutsigbarhet samt fortsatt full fokus på bedriftens primæraktiviteter.

Unoma - tilbyr bygg- og anleggsbransjen bedre oversikt oversiktlig, forbedret effektivitet og økt lønnsomhet. Kjerneproduktet er Unomaportalen, en digital plattform for små og mellomstore bedrifter i bygg- og anleggsbransjen. Med tilgang til en rekke arbeidsverktøy, kurs, tjenesteleverandører og ikke minst Norges største varedatabase i én og samme portal, vil bransjen oppleve forenkling av den daglige driften. Gjennom å tilby sømløs kommunikasjon og effektiv administrering kan vi hjelpe ditt selskap med å legge grunnlaget for sunn og lønnsom drift, mens du kan fokusere på din kjernevirksomhet.

Inspera is the leading European high-stakes digital examination platform and end-to-end solution for governments, awarding bodies, higher education institutions as well as schools. On a mission to re-invent educational assessment for the 21st century, we offer the most innovative, reliable and secure service as well as the expertise needed digitise large-scale examinations.

- an easy-to-use all-in-one solution for the HORECA industry- GastroPlanner is one of Norway's leading suppliers of online tools for HORECA (hotels, restaurants, and catering). We offer a complete platform with all the tools and integrations needed to improve and streamline the daily operation of a HORECA business.

Fjeldstad Design is a small family business that specializes in providing custom-made solutions for houses and gardens. We design products that we hope will suit most people, and design as needed. Our goal is to be able to offer good products that are produced locally and at the right price.

High levels of wind noise are a health and safety hazard for motorcycle riders. Noise levels can exceed 110 decibels at highway riding, but also reach dangerously high levels even at city-riding speeds. 95% of riders want a quieter helmet. Current measures to combat noise levels in helmets have yielded very limited results. DAAL Noise Control Systems is a Norwegian start-up tech company founded in 2016 by acoustician and motorcyclist Dag Loe and physicist Sigmund Birkeland. DAAL is currently developing an active noise control system (ANC) for MC helmets. Our system dampens wind noise without interfering with important traffic noises like car horns and sirens.